Literature DB >> 19046651

Treatments for somnambulism in adults: assessing the evidence.

Melanie Harris1, Ronald R Grunstein.   

Abstract

Somnambulism, or sleepwalking, is a parasomnia of non-rapid eye movement (NREM) sleep where movement behaviours usually confined to wakefulness are displayed during sleep. Generally, if sleepwalking is causing distress or danger in spite of safety measures, medical or psychological treatment is indicated. Clinicians will need to assess the evidence for treatment options. MEDLINE, EMBASE, PsycINFO and the Ovid Evidence-Based Medicine Reviews (EBM) multifile databases were searched. No properly powered rigorous controlled trials were found for treatment of sleepwalking in adults. Seven reports described small trials with some kind of control arm, or retrospective case series which included 30 or more patients. With no high quality evidence to underpin recommendations for treatments of somnambulism, full discussion with patients is advised. Adequately powered, well-designed clinical trials are now needed, and multi-centre collaborations may be required to obtain the sample sizes required.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19046651     DOI: 10.1016/j.smrv.2008.09.003

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  13 in total

1.  Sleepwalking, a possible side effect of antipsychotic medication.

Authors:  Mary V Seeman
Journal:  Psychiatr Q       Date:  2011-03

2.  Darwin's Predisposition and the Restlessness that Drives Sleepwalking.

Authors:  Michael Howell
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

Review 3.  Parasomnias.

Authors:  John A Fleetham; Jonathan A E Fleming
Journal:  CMAJ       Date:  2014-05-05       Impact factor: 8.262

4.  A preliminary survey on prevalence and knowledge about different aspects of somnambulism in Buner District of Khyber Pakhtunkhwa, Pakistan.

Authors:  Zaigham Hasan; Rabia Afridi; Lubna Rahman; Naveeda Akhtar Qureshi; Kausar Saeed; Humera Afridi
Journal:  Sleep Breath       Date:  2018-01-20       Impact factor: 2.816

5.  Sleep and violence.

Authors:  Maria Livia Fantini; Monica Puligheddu; Alessandro Cicolin
Journal:  Curr Treat Options Neurol       Date:  2012-10       Impact factor: 3.598

6.  Validation of the Dutch translation of the Paris Arousal Disorders Severity Scale for non-REM parasomnias in a 1-year and 1-month version.

Authors:  Petra van Mierlo; Lieke W A Hermans; Isabelle Arnulf; Angelique Pijpers; Sebastiaan Overeem; Merel M van Gilst
Journal:  J Clin Sleep Med       Date:  2022-04-01       Impact factor: 4.062

Review 7.  Parasomnias: an updated review.

Authors:  Michael J Howell
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

8.  A scale for assessing the severity of arousal disorders.

Authors:  Isabelle Arnulf; Bin Zhang; Ginevra Uguccioni; Mathilde Flamand; Alix Noël de Fontréaux; Smaranda Leu-Semenescu; Agnès Brion
Journal:  Sleep       Date:  2014-01-01       Impact factor: 5.849

9.  Substance P and the neurokinin-1 receptor regulate electroencephalogram non-rapid eye movement sleep slow-wave activity locally.

Authors:  M R Zielinski; S A Karpova; X Yang; D Gerashchenko
Journal:  Neuroscience       Date:  2014-10-06       Impact factor: 3.590

Review 10.  NonREM Disorders of Arousal and Related Parasomnias: an Updated Review.

Authors:  Muna Irfan; Carlos H Schenck; Michael J Howell
Journal:  Neurotherapeutics       Date:  2021-02-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.